Form 4 for GH Guardant Health, Inc.
Accepted 2025-03-18 00:00:00 ET · period of report 2025-03-14 · accession 0001576280-25-000086 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-18 | 2025-03-14 | GH | Talasaz AmirAli | Co-CEO, Dir | M - OptEx | $0.00 | +68.8K | 2.33M | +3% | $0 |
| D | 2025-03-18 | 2025-03-14 | GH | Talasaz AmirAli | Co-CEO, Dir | F - Tax | $42.89 | -34.9K | 2.30M | -1% | -$1.49M |
| D | 2025-03-18 | 2025-03-14 | GH | Talasaz AmirAli | Co-CEO, Dir | M - OptEx | $0.00 | -68.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-14 | M | A | 68,769 | $0.00 | 2,330,100 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-14 | F | D | 34,853 | $42.89 | 2,295,247 | D | — | — | (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| 3 | Derivative | Performance-Based Restricted Stock Units | 2025-03-14 | M | D | 68,769 | $0.00 | 0 | D | $0.00 · 2025-03-14 to — | 68,769 Common Stock | (F2) Not applicable for Restricted Stock Units. |